GoodRx is a buy that can surge 60% from here, Citi says
The sell-off in telemedicine name GoodRx is overdone, and now is a good time to buy the stock, according to Citi.
Source link
- Web3 developer platform Fleek raises $25M led by Polychain Capital
- Airline Chairman Eyes More Gains for Stock Fueling Turkey’s World-Beating Rally
